For patients suffering from the condition known as atrial fibrillation – or “A-fib” – an anti-coagulant drug is often used to help prevent the formation of deadly blood clots. For generations, doctors prescribed the drug known as warfarin to A-fib patients, until the newer blood thinning drug Xarelto was introduced... Read more »

In addition to a growing number of cases in the United States, Bayer now faces a Xarelto class action lawsuit in Canada. Plaintiff Betty Samson filed the complaint in Calgary and another is likely to follow in Ontario, where an elderly woman bled to death while taking the drug. The complaint includes... Read more »

JAMA Internal Medicine recently published a study by Charles Seife that highlights a profound flaw in how consumers obtain information about clinical drug trials. According to the New York University professor, only 4 percent of questionable practices or violations discovered by health regulators during pharmaceutical trials ever reaches the public.... Read more »

Administrative Judge Kevin Dougherty of the Philadelphia Court of Common Pleas recently issued an order that has created a mass tort docket for Xarelto lawsuits filed against Janssen Pharmaceuticals and Bayer Healthcare Pharmaceuticals. The January 21, 2015 order affects at least 75 cases that share common allegations regarding the medication,... Read more »

Fraudulent concealment, negligence and fraud are just some of the causes of action leveled against Xarelto manufacturers by a California plaintiff who suffered personal injuries after ingesting the drug. The product liability lawsuit is just one of dozens which claim the anticoagulant is defective and inherently dangerous due to its... Read more »

Over the past several years, the highly-anticipated next-generation blood thinner Xarelto has transformed from an exciting new addition to the American drug market to a potentially dangerous, even life-threatening treatment. Xarelto, which was designed and manufactured by Bayer and Johnson & Johnson subsidiary Janssen, has been named in 21 federal... Read more »

A motion to establish a multidistrict litigation (MDL) encompassing a growing number of Xarelto bleeding injury lawsuits will be heard on December 4 before the U.S. Judicial Panel on Multidistrict Litigation. The judges who are part of the panel will consider the merits of forming the MDL as a response... Read more »

The Janssen unit of Johnson & Johnson recently announced a Xarelto recall due to the discovery of a microbial contamination. To date, information regarding the exact nature of the contamination has not been released and so far it appears that no patients have suffered an illness because of the problem.... Read more »

Plaintiffs across the country have filed at least 21 Xarelto lawsuits against the maker of the popular blood thinner. The product liability lawsuits have been filed in 10 separate federal district courts. A group of the federal plaintiffs have now filed a motion for transfer requesting that the U.S. Judicial... Read more »

An 87-year-old California man has filed a Xarelto injury lawsuit against Janssen Research & Development, a subsidiary of Johnson & Johnson, and Bayer Healthcare after experiencing adverse side effects as a result of ingesting the drug. Allen Grossman allegedly suffered inter alia life-threatening bleeding and other severe and personal injuries... Read more »